Journal Mobile Options
Table of Contents
Vol. 75, No. 3, 2013
Issue release date: April 2013
Gynecol Obstet Invest 2013;75:169-174
(DOI:10.1159/000346175)

HIV-1 Seroprevalence among Pregnant Women in Rural Uganda: A Longitudinal Study over Fifteen Years

Reuschel E. · Tibananuka S. · Seelbach-Goebel B.
aDepartment of Obstetrics and Gynecology, University of Regensburg, Hospital of the Barmherzige Brueder, Clinic St. Hedwig, Regensburg, Germany; bBujumbura Convent, Hoima, Uganda

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Introduction: In order to determine the development of the prevalence of HIV infection in rural Western Uganda, data of epidemiological studies conducted in 2001 and 2007 were compared to study data from 1993. Methods: In 2001 (n = 466) and in 2007 (n = 486), one group each of clinically healthy pregnant women of a local prenatal care department were enrolled in the study and anonymously screened for HIV-1. For both groups, informed consent was obtained prior to enrolment. Testing for HIV was done by enzyme-linked immunosorbent assay (ELISA) and confirmed by Western blot. In addition, age and antibodies against syphilis were determined as risk factors of HIV infection. Results: The seroprevalence of HIV-1 infection did not decrease significantly over this time period, dropping from 28.3 to 25.1% between 2001 and 2007, but the prevalence of syphilis antibodies decreased from 27.9 to 11.1%. The data of 2001 and 2007 were compared to a third cohort from 1993, in which 21.5% of pregnant women were HIV-1-positive and 31.1% were Treponema pallidum hemagglutination assay (TPHA)-positive. Conclusion: The current prevalence of HIV-1 infection in Uganda is still high and there is a need for further promotion of HIV prevention and control services.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Zaba BW, Carpenter LM, Boerma JT, Gregson S, Nakiyingi J, Urassa M: Adjusting ante-natal clinic data for improved estimates of HIV prevalence among women in sub-Saharan Africa. AIDS 2000;14:2741-2750.
  2. Fabiani M, Fylkesnes K, Nattabi B, Ayella EO, Declich S: Evaluating two adjustment methods to extrapolate HIV prevalence from pregnant women to the general female population in sub-Saharan Africa. AIDS 2003;17:399-405.
  3. Karim QA, Sibeko S, Baxter C: Preventing HIV infection in women: a global health imperative. Clin Infect Dis 2010;50:122-129.
  4. Bunnell RE, Yanpaisarn S, Kilmarx PH, Rhodes RH, Limpakarnjanarat K, Srismith R, Mastro TD, St Louis ME: HIV-1 seroprevalence among childbearing women in northern Thailand: monitoring a rapidly evolving epidemic. AIDS 1999;13:509-515.
  5. Quinn TC: The global burden of the HIV pandemic. The Lancet 1996;348:99-106.
  6. STD/AIDS Control Programme: HIV/AIDS Surveillance Report, Kampala, Uganda Ministry of Health, 2003.
  7. Kirungi WL, Musinguzi J, Madraa E, Mulumba N, Callejja T, Ghys P, Bessinger R: Trends in antenatal HIV prevalence in urban Uganda associated with uptake of preventive sexual behaviour. Sex Transm Infect 2006;82:36-41.
  8. Assiimwe-Okiror G, Opio AA, Musinguzi J, Madraa E, Tembo G, Carael M: Change in sexual behaviour and decline in HIV infection among young pregnant women in urban Uganda. AIDS 1997;11:1757-1763.
  9. Schmalzbauer E, Tibananuka S, Froesner GG: Seroprevalence of HIV-1/2-infection in pregnant women, out- and inpatients at a hospital in Western Uganda. IX International Conference on AIDS, Berlin, 1993 (abstract PO-C07-2756).
  10. Berkley SF, Widy-Wirski R, Okware SI, Downing R, Linnan MJ, White KE, et al: Risk factors associated with HIV infection in Uganda. J Infect Dis 1989b;160:22-30.
  11. Hellman N, Nsubuga P, Baingana B, Mbidde EK, Hellmann SD: HIV infections among patients in a Ugandan STD clinic. VI International Conference on AIDS, San Francisco, 1990 (abstract THC577).
  12. Miotti PG, Chiphangwi JD, Dallabetta GA: The situation in Africa. Baillieres Clin Obstet Gyneacol 1992;6:165-186.
  13. Nsubuga P, Mugerwa R, Nsibambi J, Sewankambo N, Katabira E, Berkley S: The association of genital ulcer disease and HIV infection at a dermatology-STD clinic in Uganda. J AIDS 1990;3:1002-1005.

    External Resources

  14. Wawer MJ, Serwadda D, Gray, RH, Sewankambo NK, Li C, Nalugoda F, et al: Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS 1997;11:1023-1030.
  15. Ross A, Van der Paal L, Lubega R, Mayanja BN, Shafer LA, Whitworth J: HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS 2004;18:799-804.
  16. Fabiani M, Ayella EO, Blé C, Accorsi S, Dente MG, Onek PA, Declick S: HIV-1 prevalence among pregnant woman living in rural areas of the Gulu district (North Uganda). AIDS 2001;15:2330-2331.
  17. Sonnenburg FV: Rasches Fortschreiten der AIDS-Epidemie in einer Region in Tansania. Fortschr Med 1991a, HHLI.
  18. Lindan C, Allen S, Carael M, Nsengumuremyi F, Van de Perre P, Serufilira A, et al: Knowledge, attitudes, and perceived risk of AIDS among urban Rwandan women: relationship to HIV infection and behaviour change. AIDS 1991;5:993-1002.

    External Resources

  19. Müller O, Barugahare L, Schwartländer B, Byaruhanga E, Kataaha P, Keyeyune D, et al: HIV prevalence, attitudes and behaviour in clients of a confidential HIV testing and counselling centre in Uganda. AIDS 1992;6:869-874.

    External Resources

  20. Pool R, Nyanzi S, Whitworth JAG: Attitudes to voluntary counselling and testing for HIV among pregnant women in rural south-west Uganda. AIDS Care 2001;13:605-615.
  21. Gregson S, Donnelly CA, Parker CG, Anderson RM: Demographic approaches to the estimation of incidence of HIV-1 infection among adults from age-specific prevalence data in stable endemic conditions. AIDS 1996;10:1689-1697.

    External Resources

  22. Wilberforce KS, Gray R: HIV Infection among Uganda Women with Cervical Cancer: a retrospective study. Gynecol Obstet Invest 2007;63:222-228.
  23. Adesiyun AG, Ameh CA, Eka A: Hysterosalpingographic tubal abnormalities and HIV infection among black women with tubal infertility in sub-Saharan Africa. Gynecol Obstet Invest 2008;66:119-122.
  24. Zhang R, Zhang H, Liu X, Fu Q, Xu X, Hu X: The immunoprotective role of interleukin-10 in abnormal pregnancy outcome induced by Toxoplasma gondii infection. Gynecol Obstet Invest 2012;73:223-229.
  25. Ma Y-Y, Hsu T-Y, Shen S-Y, Huang T-S, Moh J-S, Liu C-M, Ou C-Y, Lin H: Epidemiology of group B Streptococcus ST-17 clone in pregnant women of South Taiwan. Gynecol Obstet Invest 2012;73:285-293.
  26. Kortekangas-Savolainen O, Mäkinen J, Koivusalo K, Mattila K: Hospital-diagnosed late sequelae after female Chlamydia trachomatis infections in 1990-2006 in Turku, Finland. Gynecol Obstet Invest 2012;73:299-303.
  27. Ross A, Morgan D, Lubega R, Carpenter LM, Mayanja B, Whitworth JAG: Reduced fertility associated with HIV: the contribution of pre-existing subfertility. AIDS 1999;13:2133-2141.
  28. Morrison CS, Wang J, Van Der Pol B, Padian N, Salata RA, Richardson BA: Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 2007;21:1027-1034.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50